A review of pulmonary arterial hypertension: role of ambrisentan
Robyn J BarstColumbia University College of Physicians & Surgeons, New York, NY, USAAbstract: Pulmonary arterial hypertension (PAH) is a rare fatal disease. Current disease-specific therapeutic interventions in PAH target 1 of 3 established pathways in disease pathobiology: prostacyclin, nit...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2007-03-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | https://www.dovepress.com/a-review-of-pulmonary-arterial-hypertension-role-of-ambrisentan-peer-reviewed-article-VHRM |